Clinical Trial Update: Phase I/II CT 2106 and 5-FU/FA in Colorectal Cancer [Phase 1, Phase 2]

View source ↗

Summary

This update notes the completion of a Phase I/II study evaluating CTI BioPharma's CT-2106 in combination with 5-fluorouracil and leucovorin (5-FU/FA) for colore…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• 5-fluorouracil with leucovorin (5-FU/FA) (5-fluorouracil and leucovorin)
• CT-2106

Snippet

Sponsor: CTI BioPharma | Conditions: Colorectal Cancer | Phase 1, Phase 2 | Status: COMPLETED